DEFINE-PCI Study: 60 Second Insights
Published: 20 March 2019
-
Views:
1960
-
Likes:
7
-
Views:
1960
-
Likes:
7
-
Up Next
-
46sPart 2 | Session 1 Justin Davies
-
1m 4sPart 2 | Session 2 Allen Jeremias
-
35sPart 2 | Session 3 Takashi Akasaka
-
45sPart 2 | Session 4 Bruce Samuels
-
57sPart 3 | Session 1 Justin Davies
-
43sPart 3 | Session 2 Allen Jeremias
-
23sPart 3 | Session 3 Takashi Akasaka
-
56sPart 3 | Session 4 Bruce Samuels
-
55sPart 4 | Session 1 Justin Davies
-
54sPart 4 | Session 2 Allen Jeremias
-
35sPart 4 | Session 3 Takashi Akasaka
-
42sPart 4 | Session 4 Bruce Samuels
-
45sPart 5 | Session 1 Justin Davies
-
45sPart 5 | Session 2 Allen Jeremias
-
41sPart 6 | Session 1 Justin Davies
-
59sPart 6 | Session 2 Allen Jeremias
-
52sPart 7 | Session 1 Justin Davies
-
31sPart 7 | Session 2 Allen Jeremias
-
52sPart 8 | Session 1 Justin Davies
-
51sPart 8 | Session 2 Allen Jeremias
-
26sPart 8 | Session 3 Takashi Akasaka
-
31sPart 8 | Session 4 Bruce Samuels
-
46sPart 9 | Session 1 Justin Davies
-
1m 5sPart 9 | Session 2 Allen Jeremias
-
26sPart 9 | Session 3 Takashi Akasaka
-
44sPart 9 | Session 4 Bruce Samuels
-
33sPart 10 | Session 1 Justin Davies
-
41sPart 10 | Session 2 Allen Jeremias
-
25sPart 10 | Session 3 Takashi Akasaka
-
1m 10sPart 10 | Session 4 Bruce Samuels
-
34sPart 11 | Session 1 Justin Davies
-
49sPart 11 | Session 2 Allen Jeremias
-
30sPart 11 | Session 3 Takashi Akasaka
-
52sPart 11 | Session 4 Bruce Samuels
-
42sPart 12 | Session 1 Justin Davies
-
22sPart 12 | Session 2 Allen Jeremias
-
34sPart 12 | Session 3 Takashi Akasaka
-
48sPart 12 | Session 4 Bruce Samuels
-
49sPart 1 | Session 1 Justin Davies Justin E Davies
-
44sPart 1 | Session 2 Allen Jeremias Allen Jeremias
-
31sPart 1 | Session 3 Takashi Akasaka Takashi Akasaka
Overview
A series of 60-second interviews where Justin Davies, Allen Jeremias, Takashi Akasaka and Bruce Samuels provide their thoughts on the DEFINE-FLAIR Study.
More from this programme
Part 1
How has Define-FLAIR affected your clinical practice?
Part 2
In what kind of scenarios would residual ischaemia be addressable or not?
Part 3
How does residual ischaemia impact the healthcare system?
Part 4
What has been your experience with tools like iFR co-registration?
Part 5
What's next in the research pipeline?
| 2 sessions | |
| Justin Davies | Watch now |
| Allen Jeremias | Watch now |
Part 6
How will it change your clinical practice?
| 2 sessions | |
| Justin Davies | Watch now |
| Allen Jeremias | Watch now |
Part 7
What were the key findings from DEFINE-PCI?
| 2 sessions | |
| Justin Davies | Watch now |
| Allen Jeremias | Watch now |
Part 8
Do you think the broader interventional community believes post-PCI ischaemia is a real problem?
Part 9
How is DEFINE PCI different from earlier post-PCI ischaemia studies?
Part 10
Why was DEFINE PCI done, is there precedent for post-PCI ischaemia?
Part 11
What would be surprising to see from DEFINE PCI?
Part 12